Christina Lake Cannabis Corp.
("
CLC" or the "
Company") (CSE:
CLC) is providing an update with respect to the expected timeline
for filing its audited financial statements for the fiscal year
ended November 30, 2023, the related management's discussion and
analysis and certificates of its CEO and CFO (collectively, the
"Required Documents") and its previously announced management cease
trade order ("MCTO") issued by the Company's principal regulator,
the British Columbia Securities Commission (the "BCSC"), on April
3, 2024. As previously announced, pursuant to the MCTO, the CEO and
CFO of the Company may not trade in securities of the Company until
such time as the Company files the Required Documents and the BCSC
revokes the MCTO. The MCTO does not affect the ability of other
shareholders of the Company to trade in securities of the Company.
Pursuant to the provisions of the alternative
information guidelines specified in National Policy 12-203 -
Management Cease Trade Orders ("NP 12-203"), the Company confirms
that, as of the date of this news release: (a) there have been no
material changes to the information contained in the default
announcement issued on April 3, 2024 (the "Default Announcement")
that would reasonably be expected to be material to an investor;
(b) there have been no failures by the Company to fulfill its
stated intentions with respect to satisfying the provisions of the
alternative reporting guidelines under NP 12-203; (c) there has not
been, nor is there anticipated to be, any specified default
subsequent to the default which is the subject of the Default
Announcement; and (d) there is no other material information
concerning the affairs of the Company that has not been generally
disclosed.
The Company confirms as of the date of this news
release that there is no insolvency proceeding against it and there
is no other material information concerning the affairs of the
Company that has not been disclosed. The Company expects to file
the Annual Filings as soon as they are available. At this time the
Company anticipates completion no later than June 17, 2024.
Following the filing of the Annual Filings, the financial
statements for the first quarter, ended February 28, 2024, will be
filed within five business days.
Additionally, the Company is also announcing
today that Milan Stefancik, Vice President of Sales and Marketing,
has left his position effective immediately. “On behalf of the
Board of Directors and the entire CLC team, I would like to thank
Milan for his contributions and wish him all the best with his
future endeavors,” said Mark Aiken, Chief Executive Officer.
ABOUT CLC
Christina Lake Cannabis is a licensed producer
of cannabis under the Cannabis Act. It has secured a standard
cultivation license and corresponding processing amendment from
Health Canada (March 2020 and August 2020, respectively) as well as
a research and development license (early 2020). Christina Lake
Cannabis’ facility consists of a 32-acre property, which includes
over 950,000 square feet of outdoor grow space, offices,
propagation and drying rooms, research facilities, and a facility
dedicated to processing and extraction. Christina Lake Cannabis
also owns a 99-acre plot of land adjoining its principal site. CLC
focuses its production on creating high quality extracts and
distillate for its B2B client base with proprietary strains
specifically developed for outdoor cultivation to enhance
extraction quality.
For more information about CLC, please visit:
www.christinalakecannabis.com
Jennifer SmithInvestor Relations and Media
Inquiriesinvestors@clcannabis.com 902-229-7265
Forward Looking Information and Risk
Factors
This news release contains statements and
information that may constitute "forward-looking information"
within the meaning of applicable securities legislation, including
statements identified by the use of words such as "will",
"expects", "positions", "believe", "potential" and similar words,
including negatives thereof, or other similar expressions
concerning matters that are not historical facts.
Such forward-looking information is not
representative of historical facts or information or current
condition, but instead represent only the Company's beliefs
regarding future events, plans or objectives, many of which, by
their nature, are inherently uncertain and outside of the Company's
control. Generally, such forward-looking information can be
identified by the use of forward-looking terminology such as
"plans", "expects" or "does not expect", "is expected", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words
and phrases or may contain statements that certain actions, events
or results "may", "could", "would", "might" or "will be taken",
"will continue", "will occur" or "will be achieved". The
forward-looking information contained herein may include, but is
not limited to, information concerning the estimated filing date of
the Annual Filings, and whether the British Columbia Securities
Commission will grant the Company’s application for an MCTO.
By identifying such information and statements
in this manner, the Company is alerting the reader that such
information and statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
information and statements. Some of these risks include, but are
not limited to, the risk that the Annual Filings are filed later
than anticipated, the risk that the Company’s application for an
MCTO is not successful for any reason, in which case there is a
risk that trading in the Company’s securities may halted by the
Canadian Securities Exchange and/or cease traded temporarily by the
Canadian securities commissions after the Filing Deadline until
such time as the Annual Filings are filed on SEDAR.
Although the Company has attempted to identify
important factors that could cause actual results to differ
materially from those contained in the forward-looking information,
there may be other factors that cause results not to be as
anticipated, estimated or intended.
In connection with the forward-looking
information contained in this news release, the Company has made
certain assumptions. Although the Company believes that the
assumptions and factors used in preparing, and the expectations
contained in, the forward-looking information and statements are
reasonable, undue reliance should not be placed on such information
and statements, and no assurance or guarantee can be given that
such forward-looking information and statements will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such information and
statements. The forward-looking information contained in this news
release are made as of the date of this news release, and the
Company does not undertake to update any forward-looking
information and/or forward-looking statements that are contained or
referenced herein, except in accordance with applicable securities
laws. All subsequent written and oral forward-looking information
and statements attributable to the Company or persons acting on its
behalf are expressly qualified in their entirety by this
notice.
Core Laboratories (NYSE:CLB)
過去 株価チャート
から 10 2024 まで 11 2024
Core Laboratories (NYSE:CLB)
過去 株価チャート
から 11 2023 まで 11 2024